Try our beta test site

Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery Disease (SCRIPT-CLI)

This study has been terminated.
(Failure to mobilize adequate CD34+ stem cells for minimum study treatment dose.)
Information provided by (Responsible Party):
University of Wisconsin, Madison Identifier:
First received: June 2, 2009
Last updated: December 4, 2014
Last verified: December 2014